Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
Description
Lipid nanoparticles (LNPs) are a potent delivery technology that have made it possible for the recent clinical breakthroughs in mRNA therapeutics and vaccines. A key challenge to the broader implementation of mRNA therapeutics and vaccines is the
